New child cancer drug tests successful - Houston Business Journal:

mytyhona.wordpress.com
The drug, AMD3100, was shown to reduced the growth of a tumor by more than 75 percentin mice, according to investigators who presented their findingz Friday at the 22nd annual meeting of the in San “AMD3100 works by shutting down the process that tumors need to set up vasculae systems,” Patrick Zweidler-McKay, senior investigator on the study, said in a “The drug doesn’t kill neuroblastoma cells but it prevents tumorx from growing rapidly by disrupting their blood “There is the possibilityu that this therapy coulrd help prevent neuroblastoma metastasi to the bone However, more studies are needed to investigate this theory.
” Abou t 650 children in the United States unde r the age of five are diagnosedf each year with neuroblastoma, according to the . Of those nearly two-thirds are diagnosed after the cancer has metastasizee to other parts ofthe body. For thesew patients with high-risk neuroblastoma, long-termm survival is less than 40 percent because the tumors are often resistant to traditional chemotherapy.